ArticleScientific reports2025
Machine learning to detect melanoma exploiting nuclei morphology and Spatial organization.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Towards Accurate Breslow Measurements: Mitigating Issues in Histopathological Imaging.Entropy (Basel, Switzerland) · 2026Article
- From Slide to Insight: The Emerging Alliance of Digital Pathology and AI in Melanoma Diagnostics.Cancers · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cutaneous melanoma is one of the most lethal forms of skin cancer, and its incidence is increasing globally. Its diagnosis typically relies on manual histopathological examination, a process that is both complex and time consuming. In this study, we propose an automated diagnostic tool, capable of generating interpretable results to aid clinical decision-making. A total of 146 whole slide images are included in the study, encompassing various lesion types: congenital nevi, dysplastic nevi, melanomas, and melanomas on nevi. The images were first processed using a multi-resolution image processing pipeline with the aim of segmenting nuclei, evaluating their geometrical and morphological features, as well as their spatial organization. To characterize each slide, these features were synthesized into 44 variables, which were then subjected to Linear Discriminant Analysis. Through this procedure, 18 relevant variables were identified demonstrating good performance in melanoma detection, as validated through Monte Carlo Cross-Validation. These variables were also interpreted within the framework of established histopathological diagnostic insights. By refining the analysis to the cellular level, we emulated standard clinical evaluation practices, ensuring that every aspect of the diagnostic process was accessible and verifiable by medical professionals. The proposed tool can offers significant potential to support clinicians in various tasks, such as prioritizing the analysis of critical samples and providing a secondary diagnostic opinion in complex cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.